Ankita Chakraborty, Advaitha Midde, Pritha Chakraborty, Sourin Adhikary, Simran Kumar, Navpreet Arri, Nabarun Chandra Das, Parth Sarthi Sen Gupta, Aditi Banerjee, Suprabhat Mukherjee
Metastatic colorectal carcinoma (mCRC) is one of the prevalent subtypes of human cancers and is caused by the alterations of various lifestyle and diet-associated factors. β-catenin, GSK-3β, PI3K-α, AKT1, and NF-κB p50 are known to be the critical regulators of tumorigenesis and immunopathogenesis of mCRC. Unfortunately, current drugs have limited efficacy, side effects and can lead to chemoresistance. Therefore, searching for a nontoxic, efficacious anti-mCRC agent is crucial and of utmost interest...
September 20, 2024: Journal of Cellular Biochemistry